HBCO fundamentals
An in-depth look to HOFSETH BIOCARE ASA operating, investing, and financing activities
HBCO free cash flow for Q4 23 is -11.87 M NOK. For 2023, HBCO free cash flow was -14.93 M NOK and operating cash flow was -6.73 M NOK.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: NOK
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM